Keros Therapeutics, Inc. Shareholders' Equity
Keros Therapeutics, Inc. (KROS) had Shareholders' Equity of $262.32 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-03
- 2026-06-30: Stockholders' Equity Attributable to Parent $262.32M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $285.63M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $303.13M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $703.58M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $262.32M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $285.63M 10-Q · filed 2026-08-03 |
| 2025-12-31 | $303.13M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $703.58M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $706.73M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $728.87M 10-Q · filed 2026-08-03 |
| 2024-12-31 | $571.55M 10-Q · filed 2026-08-03 |
| 2024-09-30 | $532.84M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $420.92M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $453.95M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $332.21M 10-K · filed 2026-03-04 |
| 2023-09-30 | $295.84M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $326.26M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $354.98M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $277.42M 10-K · filed 2025-02-26 |
| 2022-09-30 | $241.03M 10-Q · filed 2023-11-06 |
| 2022-06-30 | $211.21M 10-Q · filed 2023-11-06 |
| 2022-03-31 | $223.49M 10-Q · filed 2023-11-06 |
| 2021-12-31 | $243.17M 10-K · filed 2025-02-26 |
| 2021-09-30 | $218.48M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $235.66M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $248.37M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $261.72M 10-K · filed 2024-02-28 |
| 2020-09-30 | $130.76M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $141.36M 10-Q · filed 2021-11-04 |
| 2020-03-31 | -$24.87M 10-Q · filed 2021-11-04 |
| 2019-12-31 | -$19.45M 10-K · filed 2022-03-09 |
| 2019-09-30 | -$16.72M 10-Q · filed 2020-11-10 |
| 2019-06-30 | -$13.19M 10-Q · filed 2020-11-10 |
| 2019-03-31 | -$10.36M 10-Q · filed 2020-11-10 |
| 2018-12-31 | -$7.18M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |